Serbia's Galenika to be sold
This article was originally published in Scrip
Executive Summary
The Serbian government wants to sell Galenika, one of the main pharmaceutical companies in the country, for an estimated €600 million, reports Scrip’s correspondent in Zagreb, Croatia. The timing of the sale has not been announced, and the government has indicated it would prefer a private buyer.